Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Multiple Sclerosis Management Practice is a private, New York-based specialty healthcare provider focused on comprehensive management of multiple sclerosis. The organization operates a multidisciplinary MS treatment hub that combines board-certified neurology care with nursing, rehabilitation, social work, naturopathic medicine, dietitian services, cognition care, on-site MRI, and an outpatient infusion suite. Founded and led by Saud A. Sadiq, MD, FAAN, IMSMP is closely associated with the Tisch Multiple Sclerosis Research Center of New York and emphasizes integrated, patient-centered care rather than development of a proprietary therapeutic pipeline. It appears to be an operating clinical practice and service organization, not a drug development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Multiple Sclerosis Management Practice.